Market Currents
Sanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis,...
-
Wednesday, September 12, 2012, 7:18 PM ETSanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis, making it the second oral therapy that will be available on the U.S. market. The drug will compete with Novartis' (NVS) Gilenya, an oral pill which was approved by the FDA in 2010.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: